Question 1

What are the potential side effects of JTZ-951?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current anemia management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

Question 3

What tests will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I might receive a placebo instead of the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease clinical trial (NCT01971164). Contact the study team or your healthcare provider for specific answers.

What this study is about